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Abstract
Despite widespread recognition that attention-deficit/hyperactivity disorder (ADHD) is a lifelong
neurodevelopmental disorder, optimal methods of diagnosis among adults remain elusive. Substantial overlap
between ADHD symptoms and cognitive symptoms of other mental health conditions, such as depression and
anxiety, and concerns about validity in symptom reporting have made the use of neuropsychological tests in
ADHD diagnostic assessment appealing. However, past work exploring the potential diagnostic utility of
neuropsychological tests among adults has often relied on a relatively small subset of tests, has failed to include
symptom and performance validity measures, and often does not include comparison groups of participants
with commonly comorbid disorders, such as depression. The current study examined the utility of an extensive
neuropsychological measure battery for diagnosing ADHD among adults. Two hundred forty-six participants (109
ADHD, 52 depressed, 85 nondisordered controls) completed a multistage screening and assessment process,
which included a clinical interview, self, and informant report on behavior rating scales, performance and
symptom validity measures, and an extensive neuropsychological testing battery. Results indicated that
measures of working memory, sustained attention, response speed, and variability best discriminated ADHD and
non-ADHD participants. While single test measures provided performed poorly in identifying ADHD participants,
analyses revealed that a combined approach using self and informant symptom ratings, positive family history of
ADHD, and a reaction time (RT) variability measure correctly classified 87% of cases. Findings suggest that
neuropsychological test measures used in conjunction with other clinical assessments may enhance prediction
of adult ADHD diagnoses.

Public Significance Statement
Public Significance Statement: This study suggests that cognitive tests may be most useful in the diagnostic
assessment of ADHD among adults when used in combination with symptom report scales and family history
information. These results caution against the use of cognitive tests alone in the diagnostic process and
emphasize inclusion of performance validity measures and measures of depression when evaluating ADHD
among adults.
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Introduction
Once considered a disorder of childhood, it is now widely recognized that attention-deficit/hyperactivity
disorder (ADHD) is a lifelong neurodevelopmental syndrome (Kessler et al., 2005). Recent national surveys have
estimated prevalence of ADHD as high as 11% among youth (Visser et al., 2014), however, prevalence estimates
are somewhat lower among adults, ranging between 2% to 6%, depending on the criteria used (Barkley,
Murphy, & Fischer, 2008; Vitola et al., 2017). These prevalence estimates have increased over the past decade,
leading to growing concerns that ADHD may be overdiagnosed, particularly among adults (Hinshaw & Sheffler,
2014; Paris, Bhat, & Thombs, 2015). Supporting this concern, prescriptions for ADHD medications for patients
between the ages of 20 and 39 have substantially increased in the past 10 years (Johansen, Matic, &
McAlearney, 2015; Renoux, Shin, Dell’Aniello, Fergusson, & Suissa, 2016), with estimates suggesting anywhere
between a 280 and 800% increase in stimulant medication prescriptions for adults since the early 2000s.
Determining the optimal diagnostic assessment procedures for ADHD among adults remains a critical
component to the continued study of its phenomenology, correlates, developmental course, and treatment.
However, multiple challenges remain in the assessment of adult ADHD, both for research and clinical purposes.
First, many young adults, especially college students, experience occasional ADHD symptoms, particularly
inattention-disorganization (Drake, Riccio, & Hale, 2017; DuPaul, Weyandt, O’Dell, & Varejao, 2009). Thus, it may
be difficult for general medical professionals without specialized training in ADHD to differentiate between

those with sufficient symptoms and impairment to warrant a diagnosis from those with occasional or situational
difficulties (Epstein et al., 2014). This problem is also compounded by the fact that attention and concentration
difficulties are nearly identical in description to cognitive symptoms of depression and anxiety and are often
associated with similar cognitive deficits (Prevatt, Dehili, Taylor, & Marshall, 2015; Spencer, Biederman, & Mick,
2007). Second, there may be secondary gains associated with endorsement of ADHD symptoms (particularly in
college settings) including access to academic/work-related accommodations as well as stimulant medications
(Advokat, Lane, & Luo, 2011; Arria et al., 2008). Inclusion of performance validity tests (PVTs) and symptom
validity tests (SVTs) have been successful in identifying invalid symptom presentation among adults presenting
for an evaluation of ADHD (Marshall, Hoelzle, Heyerdahl, & Nelson, 2016; Musso & Gouvier, 2014). However, it
remains unclear how often issues of invalid symptom presentation are considered when evaluating the disorder
in adults. Recent expert recommendations regarding the optimal means of assessing adult ADHD have pointed
out the importance of including such validity measures (Ramsey, 2015).
Third, only the most recent revision to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM5; American Psychiatric Association, 2013) has specified adult-specific symptom wording and thresholds within
the ADHD diagnostic criteria. Thus, application of adult-specific criteria may be unfamiliar to those making the
diagnosis. The need for adult-specific symptom criteria and diagnostic thresholds caused significant debate
during the DSM revision process (Bell, 2011) and continues to be contested in the literature (Matte et al., 2015;
Sibley, Coxe, & Molina, 2017; Vitola et al., 2017). The current criteria rely on reports of current symptoms as well
as retrospective reports of childhood behavior prior to Age 12. The accuracy of retrospective self-reports of
childhood behavior remains somewhat questionable (Mannuzza, Klein, Klein, Bessler, & Shrout, 2002). However,
prior work has demonstrated that specifying presence of symptoms before Age 12 (compared with Age 7 in
DSM–IV) likely improved reliability of retrospective reports of symptoms while not substantially increasing the
prevalence of adult ADHD (Kieling et al., 2010). Notably, the accuracy of diagnostic assessment of ADHD may be
improved by including reports of symptoms from informants, such as parents (Dvorsky, Langberg, Molitor, &
Bourchtein, 2016; Sibley et al., 2017) as well as considering family history of ADHD (Kooij et al., 2010), given
work indicating significant heritability of ADHD (Nikolas & Burt, 2010). However, few studies have explicitly
examined the extent to which inclusion of such information enhances diagnostic prediction.
In general, an unstructured clinical interview combined with self-reports on behavioral rating scales of ADHD
symptoms remain the most common tools used in diagnosing ADHD among adults (Dvorsky et al., 2016; Nelson,
Whipple, Lindstrom, & Foels, 2014). Using neuropsychological testing has been proposed as one strategy to
improve the accuracy of diagnostic assessment, given the range of cognitive deficits associated with ADHD in
adulthood (Mostert et al., 2015; Weyandt, Oster, Gudmundsdottir, DuPaul, & Anastopoulos, 2017) as well as the
continuation of neurocognitive problems into adulthood among those with ADHD (van Lieshout, Luman,
Buitelaar, Rommelse, & Oosterlaan, 2013). Some past work has shown that inclusion of tests of executive
functioning, particularly working memory and inhibition, as well as tests of sustained attention have improved
diagnostic accuracy of ADHD assessment (Grodzinsky & Barkley, 1999; Lovejoy et al., 1999). More recently,
machine learning paradigms have also been able to utilize neuropsychological data to accurately predict ADHD
diagnoses among children (Bledsoe et al., 2016). However, other studies have also shown limited utility of these
neuropsychological tests in improving diagnostic accuracy (Barkley et al., 2008; Rapport, Van Voorhis, Tzelepis,
& Friedman, 2001). Notably, single neuropsychological tests have been found to poorly discriminate between
youth with and without ADHD (Doyle, Biederman, Seidman, Weber, & Faraone, 2000) and normal performance
on any given test has been shown to poorly predict the absence of ADHD (Perugini, Harvey, Lovejoy, Sandstrom,
& Webb, 2000). This is likely due to the substantial heterogeneity in neuropsychological performance among
those with and without ADHD (Fair, Bathula, Nikolas, & Nigg, 2012).
While there is some indication that combined approaches (i.e., interview, behavior rating scale, and
neuropsychological testing) may provide improved diagnostic accuracy (Perugini et al., 2000), past work
exploring these questions has been limited in several ways. First, many studies have focused on a few

neuropsychological domains and have not incorporated other tests commonly used in clinical
neuropsychological practice, which may potentially be more sensitive in identifying ADHD-related cognitive
deficits. Second, nearly all this work has failed to incorporate PVTs to ensure valid effort. Third, only one study of
the diagnostic accuracy of a combined approach (including PVTs) has been done with adults, a group for which
diagnosis remains particularly challenging. Many of these studies have failed to consider how measures might
distinguish ADHD from those with other disorders, such as depression, that present with similar concentration
and attention problems. Distinguishing between adult ADHD and depression is of particular importance, given
the high rates of comorbidity between ADHD and depression in adults (Kessler et al., 2006) as well the common
patterns of cognitive deficits associated with each condition (Prevatt et al., 2015; Spencer et al., 2007). Few prior
studies have evaluated the degree to which each source of information (i.e., rating scales, test scores) improves
diagnostic accuracy as well as how various cut scores available across many commonly used measures may
impact their diagnostic utility.
Therefore, the purpose of the current study was to examine performance across a large and diverse
neuropsychological measure battery among adults with ADHD, adults with unipolar depression, and controls
with the goal of determining if inclusion of such measures improved diagnostic accuracy of ADHD. Here, we also
examined behavior rating scales from participants and informants that assessed current and childhood
symptoms as well as current ADHD-related functional impairments, along with neuropsychological test
performance to determine which combination of these measures resulted in the highest diagnostic accuracy of
ADHD among adults. Based on prior work, we predicted that inclusion of tests of neuropsychological
functioning, particularly sustained attention, would improve diagnostic accuracy for adult ADHD.

Method
Participants
Participants were 256 adults Ages 18–40 years (Mage = 23.9 years, SD = 5.1 years, 60.6% female, 83.7%
Caucasian). Adult volunteers were recruited via advertisements, e-mail listservs, and outreach to local
neuropsychological clinics to obtain as representative a sample as possible while avoiding the inherent biases
associated with relying on a purely clinic-referred sample. Study participants were recruited across two sites into
one of three potential groups: adults with a diagnosis of ADHD, adults with a diagnosis of unipolar mood
disorder (depressed), and adults with neither diagnosis (controls, see the Testing Procedures section).
Enrollment in the study also required all participants to give contact information for an informant, who could
provide reports regarding their current and childhood ADHD symptoms. Demographic characteristics (i.e., age,
sex, ethnicity, household income) did not vary by recruitment location (all ps >.22).
A multistage process was used to identify cases and noncases among those who volunteered (see Figure 1).
Interested participants first completed an eligibility screening process conducted by bachelor’s and master’s
level research project staff at Stage 1 to evaluate inclusion and exclusion criteria. Participants were excluded if
they (a) were not fluent in English; (b) had any physical illness or neurological conditions, including a history of
head injuries, which might compromise central nervous system and cognitive functioning; (c) had a history of
major psychiatric disorder other than depression or anxiety disorders; (d) had ever been diagnosed with a
learning disability, (5) had a history of preterm birth (birth prior to 33 weeks gestation); or (e) had significant
alcohol, illicit drug, or prescription drug abuse (based on the frequency, number of years of use, and total
amount used per week), that were considered capable of causing impaired cognitive testing performance. While
prior work has been somewhat inconsistent in including/excluding individuals with comorbid
neurodevelopmental problems, including learning disorders, we elected to take a conservative approach and
exclude those with other neurodevelopmental conditions to ensure that any cognitive deficits we observed
were due to ADHD and not a combination of different problems. Additionally, participants were excluded if they
were taking long-acting stimulant medications (n = 77) or were not willing to complete a wash out of stimulant

medication prior to testing (n = 12). A total of 882 participants completed the initial screening process, of which
282 were excluded.

Figure 1. Multistage recruitment procedure.
Following the initial screening process, the remaining 600 eligible participants completed the Stage 2 screening
to determine diagnostic grouping. To be considered for the ADHD group, participants had to endorse having a
prior diagnosis based upon a comprehensive clinical interview and standardized assessment of psychiatric status
(i.e., behavioral rating scales) as well as onset of symptoms and impairment prior to Age 16. Any prior diagnosis
had to have been made during the preceding 4 years. Participants had to meet full DSM–5 diagnostic criteria to
be retained in the ADHD group. To determine final inclusion in the ADHD group, potential ADHD participants
completed a semistructured interview of adult ADHD symptoms based on Kessler et al. (2010) to ensure that
current and childhood symptoms were above DSM–IV/DSM–5 diagnostic thresholds. These thresholds include
6+ symptoms present during childhood prior to Age 12 and 5+ symptoms present within the past 6 months. A
total of 307 potential ADHD participants completed the Stage 2 screening, and 109 were deemed eligible and
enrolled in the study.
To be included in the depressed group, participants had to endorse receiving a diagnosis of a unipolar mood
disorder from a mental health professional based upon a comprehensive clinical interview and standardized
assessment of psychiatric status. Additionally, participants had to endorse having at least one mood episode
during the past year that required either medication or behavioral treatment. We set these criteria in order to
try to closely compare cognitive performance of individuals with ADHD and those with recent, active symptoms
of depression. A total of 182 potential depressed group participants completed the Stage 2 screening, and 52
were deemed eligible and enrolled in the study.
Lastly, (out of the 111 screened) 85 community volunteers presenting with no history of either ADHD or unipolar
mood disorder were enrolled in the study as controls. While a formal matching process was not implemented,
control participants were enrolled to approximately correspond to the clinical groups based on age and sex.
Screening procedures resulted in a total sample of 246 participants (109 ADHD, 52 depressed, and 85 controls).
All participants completed a standardized neuropsychological testing battery and questionnaire measures, as
follows. Additionally, all participants were compensated for their time and parking expenses were paid. All
procedures were approved by the local institutional boards.

Testing Procedures
Each participant completed a comprehensive neuropsychological evaluation, consistent with recommendations
for a multimethod assessment of adult ADHD (Frazier, Demaree, & Youngstrom, 2004; Weyandt et al., 2013).
The testing procedures included multiple cognitive tests, behavioral observations, self and informant ADHD
behavior rating scales, ratings of depression and anxiety symptoms, PVTs, and an SVT. All participants taking
stimulant medication completed a 24- or 48-hr wash-out procedure, depending on whether the medicine was
short or long acting (M wash-out time = 37.4 hr, SD = 14.6). The cognitive tests were administered according to
standardized instructions by trained and supervised clinical psychology doctoral students and advanced
undergraduate students. The tests were administered in the same order for all participants (Marshall et al.,
2016). Tests were selected based on review of three meta-analyses of neuropsychological performance among
adults with ADHD (Alderson, Kasper, Hudec, & Patros, 2013; Boonstra, Oosterlaan, Sergeant, & Buitelaar, 2005;
Hervey, Epstein, & Curry, 2004) and were included to cover several broad domains, including executive
functioning (e.g., working memory, inhibition, set-shifting, interference control, planning), memory, processing
speed, and sustained attention/vigilance. Included tests had a conceptual and empirical association with ADHD
and the battery was selected to adequately cover verbal, visual, and motor processing domains.
Participants completed the Vocabulary, Block Design, Digit Span, and Symbol Search subtests of the Wechsler
Adult Intelligence Scale (4th ed.; Wechsler, 2008a); the California Verbal Learning Test-II (CLVT-II; Delis, Kramer,
Kaplan, & Ober, 2000); the Verbal Fluency, Design Fluency, Color-Word Interference Test (CWIT), and Tower test
from the Delis-Kaplan Executive Function System (DKEFS; Delis, Kaplan, & Kramer, 2001); the
Neuropsychological Assessment Battery (NAB) Numbers and Letters Test (White & Stern, 2003); the Word
Memory Test (WMT; Green, 2003); the Paced Auditory Serial Addition Test (PASAT-100; Diehr et al., 2003); the
Salthouse Listening Span Test (Salthouse, 1994); the Test of Variables of Attention (TOVA; Greenberg, Kindschi,
Dupuy, & Corman, 1996); the Dot Counting Test (Boone, Lu, & Herzberg, 2002b); the Sentence Repetition Test
(Strauss, Sherman, & Spreen, 2006); the Spatial Addition subtest of the Wechsler Memory Scales (4th ed.;
Wechsler, 2008b), and the b-Test (Boone, Lu, & Herzberg, 2002a). PVT measures were interspersed throughout
the testing battery, given that effort can fluctuate significantly throughout a testing session (Boone, 2009). The
following PVT cutoff scores were used to identify suspect effort per Marshall et al. (2016): a score of 6 or less on
the Reliable Digit Span score (Babikian, Boone, Lu, & Arnold, 2006), two or more errors on the Forced Choice
Recognition Test of the CVLT-II (Root, Robbins, Chang, & Van Gorp, 2006), a Sentence Repetition score of 10 or
less (Schroeder & Marshall, 2010), and less than 82.5% correct for the immediate recognition, delay recognition,
or recall consistency scores on the WMT (Green, 2003). Further, an e-score of 14 or greater on the Dot Counting
Test, e score of 70 or more on the b-Test, and response variability values of greater than 180 ms, 26 or more
omission errors, and 31 or more commission errors on the TOVA were used to identify suspect effort.
Following the completion of the testing battery, participants completed several normed behavior rating scales to
assess ADHD, depression, and anxiety symptomatology. Both participants and their informants completed the
current and childhood symptom versions of the Barkley Adult ADHD Rating Scale (BAARS-IV, Barkley, 2011a), the
Barkley Deficits in Executive Function Scale—Short Form (BDEFS-SF; Barkley, 2011b), and the Barkley Functional
Impairment Scale (BFIS, Barkley, 2011c). The BAARS-IV requires respondents to rate the frequency of all 18
DSM–IV ADHD symptoms on a 4-point Likert scale (never/rarely, sometimes, often, and very often). Additionally,
both participants and their informants completed the BDEFS-SF (Barkley, 2011b). The BDEFS requires
respondents to report the frequency of various executive function-related problems on a 4-point Likert scale
(never/rarely, sometimes, often, and very often), including difficulties with time management, organization,
restraint, motivation, and emotion regulation. Participants and their informants also completed the BFIS
(Barkley, 2011c). The BFIS requires respondents to report the degree to which they believe their ADHD
symptoms are impairing their functioning across multiple domains (e.g., in completing tasks at home, in their
interpersonal relationships, in their work/school activities). Lastly, participants also completed the Beck
Depression Inventory-II (Beck, Steer, & Brown, 1996), a 21-item scale examining the severity of depression
symptoms as well as the 21-item Beck Anxiety Inventory (Beck & Steer, 1993), which quantifies the severity of

anxiety symptoms. Finally, both participants and informants also completed the Clinical Assessment of Attention
Deficit–Adult Infrequency scale (Bracken & Boatwright, 2005) which is an SVT. The endorsement of three or
more of the 10 items on this scale was considered to be indicative of symptom exaggeration or embellishment
(Marshall et al., 2016).

Data Analytic Strategy
Descriptive statistics for the diagnostic measures were first calculated by group (ADHD, depressed, and control)
and differences evaluated via analysis of variance. To facilitate interpretation of results, all neuropsychological
test scores were transformed to reduce skewness and mean centered, such that higher scores reflected worse
performance. Normed values were used for each measure to manage differences related to age and sex.
Participants who were below thresholds on two or more PVT/SVTs were determined to have made an invalid
symptom presentation (n = 6, all in the ADHD group), based on prior work (Marshall et al., 2016).
Prior to conducting the primary analyses, the diagnostic accuracy of each neuropsychological test measure was
preliminarily assessed via calculation of the area under the curve (AUC) via a series of receiver operator
characteristic (ROC) analyses. These analyses examined the utility of each measure in distinguishing each dyadic
grouping (i.e., ADHD vs. non-ADHD, ADHD vs. control, and ADHD vs. depressed). Measures with AUC values
significantly greater than .50 (which represents the probability that a test score will rank a randomly chosen case
higher than a randomly chosen noncase) were retained for the primary analyses.
Regression analyses were then conducted to evaluate our primary questions regarding the utility of
neuropsychological test measures for distinguishing adult ADHD. Specifically, a series of stepwise binary logistic
regression analyses as well as a multinomial logistic regression were conducted to determine which measures
best distinguished participants with ADHD from those without ADHD (including controls and patients with
depression). In these models, all neuropsychological test measures were included as predictors and an iterative
process was used to determine the best fitting model. Standardized, mean-centered scores were used as the
predictors (all skewness <.70) and estimated full-scale IQ and stimulant medication status were included as
covariates. Outcomes included binary diagnostic groupings (i.e., ADHD vs. non-ADHD, ADHD vs. control, ADHD
vs. depressed) and the three-group multinomial comparison (i.e., ADHD vs. control vs. depressed). Model fit was
evaluated using the omnibus chi-square as well as the Hosmer and Lemeshow chi-square statistics. In addition
to models predicting diagnostic group, additional analyses also examined test measures as predictors of
dimensional scores of ADHD symptom severity and impairment (mean of self- and informant ratings) using a
stepwise linear regression framework. Neuropsychological test measures that were found to significantly and
incrementally contribute to the prediction of group membership and/or the variance in symptom severity were
then retained for a subset of further analyses.
Next, we utilized a series of procedures to determine the best method for combining rating scale and test data
for predicting diagnostic grouping. First, specific cut scores that optimized sensitivity, specificity, positive
predictive power, and negative predictive power were determined for a final subset of neuropsychological test
measures based on the prior analyses. We retained measures that were found to: (a) have marginal or better
(>.60) AUC values, and (b) significantly and incrementally contribute to the prediction of diagnostic group and/or
symptom severity variance. From here, we utilized a series of stepwise binary logistic regression analyses to
determine the degree to which each of the following indicators improved prediction of ADHD diagnoses: (a) selfreports of current symptoms and impairment, (b) self-report of childhood symptoms, (c) informant reports of
current symptoms, (d) family history of ADHD diagnosis, and (e) our subset of best-performing
neuropsychological test cut scores.

Results
Descriptive Statistics
Demographic and descriptive statistics for the sample are presented in Table 1. As seen there, our recruitment
and diagnostic assessment procedures were effective in distinguishing our groups. As expected, adults in the
ADHD group had significantly higher levels of inattention and hyperactivity-impulsivity symptoms, both currently
and during childhood. They were significantly more likely to be taking stimulant medication than those in the
depressed or nondisordered control groups. Notably, adults in the depressed group had significantly higher
scores on the BDI than the ADHD and control groups. While adults in the depressed group reported higher levels
of ADHD symptoms compared with controls, these did not reach clinical diagnostic thresholds. As expected,
there was a higher proportion of males in the ADHD group relative to the depressed and control groups.
Importantly, however, the three groups did not differ in regard to age, ethnicity, and years of education.
Notably, average IQ and education were generally above average relative to population norms.
Table 1. Demographic and Descriptive Statistics for ADHD and Non-ADHD Control and Depressed Participants
Sample characteristic
Control
ADHD
Depressed p value Diff
N
85
109
52
Male (%)
32.9
49.5
28.8
.01
A, C > D
Caucasian (%)
80.0
85.3
86.5
.29
Age
22.9 (4.5) 24.8 (6.2) 23.6 (5.4)
.06
Education (years)
14.9 (1.9) 15.4 (2.5) 15.0 (2.2)
.24
Stimulant medication (%)
0
76.1
0
<.001
A > D, C
Current inattention symptoms
.62 (1.4)
5.1 (2.8)
2.4 (2.8)
<.001
A>D>C
Current hyperactive-impulsive symptoms
.95 (1.5)
3.9 (2.4)
1.9 (2.3)
<.001
A>D>C
Childhood inattention symptoms
1.0 (2.0)
5.5 (3.1)
1.8 (2.6)
<.001
A > D, C
Childhood hyperactive-impulsive symptoms
1.3 (1.9)
4.6 (3.1)
1.9 (2.4)
<.001
A > D, C
BDEFS percentile score
56.0 (21.4) 84.7 (15.9) 78.9 (19.4) <.001
A, D > C
BFIS percentile score
58.6 (12.9) 77.1 (15.0) 74.0 (16.6) <.001
A, D > C
Informant inattention symptoms
.43 (1.1)
4.0 (2.7)
1.9 (2.3)
<.001
A>D>C
Information hyperactive-impulsive symptoms .58 (1.4)
3.3 (2.7)
1.2 (1.8)
<.001
A > D, C
Beck Depression Inventory score
5.0 (5.1)
10.5 (8.2) 16.0 (10.9) <.001
D>A>C
Beck Anxiety Inventory score
2.8 (5.1)
8.5 (8.8)
9.4 (9.1)
<.001
D, A > C
Note. p value indicates significant difference at level of three groups. Stimulant medication indicates proportion
of participants taking stimulant medication at time of assessment (and how underwent washout procedure).
Values in parentheses are standard deviations. Diff _ pattern of post hoc group differences; BDEFS _ Barkley
Deficits in Executive Function Scale; BFIS = Barkley Functional Impairment Scale; A = attentiondeficit/hyperactivity disorder (ADHD); D = depressed, C = control.

Neuropsychological Test Measures
ROC analyses indicated that several test measures were marginal or better predictors of diagnostic group
membership (Table 2). These analyses were first conducted examining measures distinguishing ADHD versus all
non-ADHD participants (depressed and control patients both) followed by analyses distinguishing ADHD versus
control and ADHD versus depressed group membership. Notably these analyses produced completely
overlapping results and identified several test measures for inclusion in subsequent regression analyses. These
measures included: CVLT short delay free recall, all three indices from the Salthouse Listening Span Test, DKEFS
Letter Fluency, DKEFS CWIT inhibition/switching, DKEFS Design Fluency test filled and empty dots, and the
reaction time (RT) variability, RT, omission errors, and d-prime score from the TOVA, and the speed score from
the NAB Numbers and Letters test.

Table 2. Receiver Operating Characteristic Analyses for Neurocognitive Test Measures: ADHD Versus Non-ADHD
Neurocognitive measures
AUC p value 95% CI
CVLT Trial 1
.51
.91
[.43, .58]
CVLT Trial 5
.55
.17
[.48, .63]
CVLT short delay free recall
.59 .01
[.52, .66]a,b
CVLT long delay free recall
.56
.12
[.48, .64]
CVLT recognition
.51
.81
[.43, .58]
Listening Span trials
.63 <.001
[.56, .70]a,b
Listening Span items
.61 .003
[.54, .68]a,b
Listening Span score
.62 .001
[.55, .69]a
Sentence repetition
.55
.18
[.48, .62]
WMS Spatial Addition
.53
.37
[.46, .61]
Letter fluency
.58 .03
[.51, .65]a
Color naming
.52
.53
[.45, .60]
Word reading
.55
.22
[.47, .62]
Inhibition
.53
.44
[.46, .60]
Inhibition/switching
.60 .009
[.53, .67]a,b
Design Fluency filled
.59 .02
[.51, .66]a
Design Fluency empty
.58 .03
[.51, .66]a
Design Fluency switching
.55
.16
[.48, .63]
Tower
.56
.12
[.49, .63]
PASAT
.49
.73.
[41, .55]
TOVA reaction time variability .66 <.001
[.59, .74]a,b
TOVA reaction time
.65 <.001
[.58, .72]a,b
TOVA commission errors
.56
.15
[.48, .63]
TOVA omission errors
.66 <.001
[.59, .73]a,b
TOVA d-prime
.64 <.001
[.57, .72]a,b
Numbers and letters speed
.59 .04
[.51, .67]a
Numbers and letters efficiency .43
.07
[.36, .50]
Note. Bolded measures had AUC scores significantly greater than .50. ADHD = attention-deficit/hyperactivity
disorder; AUC = area under the curve; CVLT = California Verbal Learning Test; WMS = Wechsler Memory Scales;
PASAT = Paced Auditory Serial Addition Test; TOVA = Test of Variables of Attention.
a
Scores indicate significant AUC in analyses examining ADHD versus controls.
b
Scores with indicate significant AUC in analyses examining ADHD versus depressed.

Predicting Diagnostic Group Membership
ADHD versus non-ADHD
Stepwise binary logistic regression analyses were first used to examine these test measures as predictors of
group status (ADHD vs. non-ADHD, including both individuals in the depressed and the control groups; Table 3).
Findings indicated that the best-fitting model included five significant test measures as predictors of ADHD
diagnostic status and improved model fit compared with the intercept-only model (omnibus χ2 = 44.7, p < .001;
Hosmer and Lemeshow χ2 = 11.2, p = .19; Nagelkerke R2 = .23). Examination of parameters indicated that worse
performance (indexed by higher scores) on CVLT short-delay free recall (β = .33, p = .029, odds ratio (OR) = 1.4,
95% CI [1.03, 1.9]), Salthouse Listening Span trials (β = .35, p = .021, OR = 1.4, 95% CI [1.1, 1.9]), DKEFS CWIT
inhibition/switching (β = .37, p = .012, OR = 1.5, 95% CI [1.1, 1.9]), TOVA RT variability (β = .36, p = .030, OR = 1.4,
95% CI [1.0, 2.0]), and TOVA omission errors (β = .43, p = .01, OR = 1.5, 95% [CI 1.1, 2.1]) all significantly and

incrementally predicted membership in the ADHD group compared with the non-ADHD group, with an overall
classification accuracy of 72.1%.
Table 3. Neurocognitive Test Measures as Predictors of ADHD Diagnostic Groupings: Stepwise Logistic
Regression Analyses
Measure
β
p value OR CI
ADHD vs. non-ADHD
CVLT short delay
.33 .029
1.4 [1.03, 1.9]
Listening span
.35 .021
1.4 [1.1, 1.9]
CW inhibition/switching
.37 .012
1.5 [1.1, 1.9]
TOVA reaction time variability .36 .030
1.4 [1.1, 2.0]
TOVA omission errors
.43 .010
1.5 [1.1, 2.1]
ADHD vs. control
Listening Span
.45 .008
1.6 [1.1, 2.2]
TOVA omission errors
.73 <.001
2.1 [1.5, 3.0]
ADHD vs. depressed
CVLT short delay
.37 .039
1.4 [1.0, 2.1]
TOVA reaction time
.48 .008
1.6 [1.1, 2.3]
Three-group multinomial
Listening Span
.46 .006
1.6 [1.1, 2.2]
TOVA omission errors
.72 <.001
2.1 [1.5, 3.0]
Note. β = betas from logistic regression analyses; ADHD _ attention-deficit/hyperactivity disorder; OR _ odds
ratio; CI _ 95% confidence interval for odds ratio; CVLT California Verbal Learning Test; CW = Color-Word; TOVA
_ Test of Variables of Attention.

ADHD versus control
A second stepwise binary logistic regression analyses was conducted to determine which neuropsychological
test measures best distinguished participants with ADHD from nondisordered controls. Here, findings indicated
that the best-fitting model included two predictors and improved model fit relative to the intercept-only model
(omnibus χ2 = 30.1, p < .001; Hosmer and Lemeshow χ2 = 6.4, p = .61; Nagelkerke R2 = .20). In this model, worse
performance on both Salthouse Listening Span trials (β = .45, p = .008, OR = 1.6, 95% CI [1.1, 2.2]) and TOVA
omission errors (β = .73, p < .001, OR = 2.1, 95% CI [1.5, 3.0]) significantly predicted membership in the ADHD
group compared with nondisordered controls, with a classification accuracy of 68.3%.

ADHD versus depressed
A third stepwise binary logistic regression analysis was used to determine which test measures best
distinguished ADHD participants from those with the depression. Again, two test measures emerged as
predictors in the best-fitting model, which exhibited improved fit relative to the intercept-only model (omnibus
χ2 = 12.8, p = .002; Hosmer and Lemeshow χ2 = 7.7, p = .47; Nagelkerke R2 = .11). Worse performance on the
CVLT short-delay free recall (β = .37, p = .039, OR = 1.4, 95% CI [1.0, 2.1]) and TOVA RT (β = .48, p = .008, OR =
1.6, 95% CI [1.1, 2.3]) were associated with membership in the ADHD group relative to the depressed group,
with a classification accuracy of 70.4%.

Multinomial logistic regression
Similarly, a stepwise multinomial logistic regression analysis was conducted to determine which
neuropsychological test measures distinguished best among all three groups. The iterative procedure again
revealed two measures best distinguished the three groups and improved model fit relative the intercept-only
model (omnibus χ2 = 34.3, p < .001; Hosmer and Lemeshow χ2 = 16.3, p = .46; Nagelkerke R2 = .15). Again, worse

performance on both the Salthouse Listening Span trials (β = .46, p = .006, OR = 1.6, 95% CI [1.1, 2.2]) and TOVA
omission errors (β = .72, p < .001, OR = 2.1, 95% CI [1.5, 3.0]) significantly predicted membership in the ADHD
group compared with nondisordered controls. However, neither measure distinguished depressed patients from
controls (all ps > .26).

Predicting Symptom Severity and Impairment
Stepwise linear regression analyses were then conducted to determine which test measures best predicted
dimensional scores of inattention, hyperactivity-impulsivity, and functional impairment (Table 4). All models
included current stimulant medication usage and estimated full-scale IQ as covariates. Two measures (TOVA RT
variability, DKEFS CWIT inhibition/switching) each contributed incrementally to predicting inattention and
together combined to predict 8% of the variance in these symptom severity scores. By contrast, TOVA omission
errors and Salthouse Listening Span trials each uniquely predicted hyperactivity—impulsivity and accounted for
6% of the variance. TOVA RT variability and CVLT short delay free recall each predicted scores on the BDEFS-SF
and together accounted for 8% of the variance. TOVA RT and Salthouse Listening Span trials both predicted
functional impairment due to ADHD symptoms as reported on the BFIS and accounted for 6% of the variance.
Thus, it appears that variability in neurocognitive functioning, specifically, in sustained attention and working
memory functioning accounted for unique variation in severity of symptoms and impairment.
Table 4. Neurocognitive Test Measures as Predictors of Ratings of ADHD Symptom Severity, Executive Function
Deficits, and Functional Impairments: Stepwise Linear Regression Analyses
Predictor

b

Β

p
value

Current inattention sum score (mean self and informant)
TOVA reaction time variability

.23 .23 <.001

CW inhibition/switching

.16 .16 <.001

Current hyperactivity-impulsivity sum score (mean self and
informant)
TOCA omission errors

.22 .22 <.001

Listening Span trials

.12 .13 .034

BDEFS percentile
TOVA reaction time variability

.27 .27 <.001

CVLT short delay free recall

.13 .13 .03

BFIS percentile
TOVA reaction time

.17 .17 .01

95% CI

R2 (Δ R2)

[.21,
.34]
[.06,
.26]

.35
(.08)

[.11,
.33]
[.01,
.23]

.21
(.06)

[.10,
.44]
[.05,
.21]

.20
(.08)

[.04,
.30]
Listening Span trials
.17 .17 .006
[.05,
.15
.29]
(.06)
Note. Total R2 value is for full model including covariates of IQ and stimulant medication. Change in R2 (ΔR2)
represents the incremental variance explained by the neurocognitive measures. ADHD = attentiondeficit/hyperactivity disorder; TOVA = Test of Variables of Attention; CW = Color-Word; CVLT = California Verbal
Learning Test; BDEFS = Barkley Deficits in Executive Function Scale; BFIS = Barkley Functional Impairment Scale.

Determining Cut Scores and Individual Test Diagnostic
Individual neuropsychological test measures
Overall, six test measures consistently emerged when predicting diagnostic group membership as well as
symptom severity and ADHD-related impairments: CVLT short delay free recall, Salthouse Listening Span trials,
DKEFS CWIT inhibition/switching condition, and the RT variability, RT, and omission errors indices from the
TOVA. We utilized the ROC data to calculate cut scores for each measure that maximized sensitivity and
specificity for each in predicting ADHD group membership. We calculated Youden’s J statistics for each potential
cut-score (defined as sensitivity + specificity − 1), which specify the score that can maximize both sensitivity and
specificity for each measure. Results are presented in Table 5. Overall, the cut scores identified as most optimal
for distinguishing ADHD and non-ADHD participants were generally within the average range compared with the
established norms for each test measure, which is consistent with the above average levels of education and
above average IQ of the sample.
Table 5. Optimizing Sensitivity and Specificity for Key Neurocognitive Test Predictors of ADHD Diagnosis and
Symptom Severity
Test measure and cut-score
Sensitivity Specificity cPPP cNPP Youden
CVLT short delay free recall
<-.75
.22
.97
3.0
.80
.19
.43
.77
1.69 .76
.20
<-.25
<.25
.54
.59
1.32 .78
.13
<.75
.67
.40
1.13 .81
.07
Salthouse Listening Span trials
.25
.88
.73
.48
.13
<7
.40
.81
.73
.51
.21
<8
.59
.66
.69
.55
.25
<9
.74
.46
.63
.58
.20
<10
DKEFS inhibition/switching
.13
.95
.78
.46
.08
<8
.23
.88
.71
.47
.11
<9
.41
.68
.63
.48
.09
<10
.55
.54
.61
.48
.09
<11
TOVA reaction time
variability
.37
.91
.83
.53
.28
<80
.47
.85
.80
.55
.32
<85
.51
.82
.79
.60
.33
<95
.66
.68
.73
.61
.34
<100
.75
.46
.64
.59
.21
<105
TOVA reaction time
.32
.84
.71
.49
.16
<100
.40
.79
.71
.51
.19
<105
.55
.70
.69
.54
.25
<110
.64
.60
.67
.57
.24
<115
.72
.47
.64
.57
.19
<120
TOVA omission errors
.39
.89
.82
.53
.28
<90
.50
.85
.81
.57
.35
<95
.58
.75
.75
.58
.33
<100

.72
.51
.65
.58
.26
<105
Note. Bolded values indicate optimal cut score for each measure based on Youden statistics. Corrected positive
and negative predictive power used estimated base rate of 30 percent. Scores for California Verbal Learning Test
(CVLT) Short Delay Free Recall are z scores. Scores from Salthouse Listening Span Trials are raw scores. Scores
from Delis-Kaplan Executive Function System (DKEFS) Inhibition/Switching are scaled scores. Scores from Test of
Variables of Attention (TOVA) measures are standard scores. cPPP = corrected positive predictive power; cNPP =
corrected negative predictive power.

Combining rating scale and neuropsychological test measures
We next evaluated the utility of using these cut scores in combination with rating scale information. A stepwise
binary logistic regression was used to examine self-reports of current symptoms and impairment, informant
reports of current symptoms and impairment, family history of ADHD, and neuropsychological test measure cut
scores as predictors of ADHD diagnostic status. Each step of the model retained significant unique predictors
and eliminated nonsignificant predictors (Table 6). Results indicated that self-reports of ADHD and depression
symptoms significantly distinguished ADHD from non-ADHD participants. Addition of retrospective childhood
reports as well as informant reports to the model at Steps 2 and 3 also significantly improved classification
accuracy. Notably, reports of family history of ADHD diagnosis in first-degree family members also significantly
improved classification accuracy, particularly for ADHD participants. Of our six neuropsychological test
measures, only TOVA RT variability added incrementally to predicting group membership. However, the OR was
relatively larger (OR = 3.1) and classification accuracy improved to 87.2% (from 85.4%), suggesting that addition
of this one neuropsychological test did improve diagnostic classification within this sample.
Table 6. Diagnostic Accuracy of Combined Approach: Self-Ratings of Current Symptoms, Childhood Symptoms,
Informant Ratings, Family History, and Neurocognitive Test Cut Scores in Predicting ADHD and Non-ADHD Group
Status
Included information
Step 1: self-report current behavior
Current ADHD symptom score
Current BDI score
Step 2: self-report childhood
behavior
Childhood inattention symptoms
Step 3: informant report current
behavior
Informant ADHD symptom score

β

p

OR (CI)

Classification accuracy (non-ADHD,
ADHD)

.16
-.06

<.001
.008

1.2 [1.1, 1.3]
.94 [.90, .98]

.12

.009

1.12 [1.03,
1.21]

80.9 (80.3, 81.6)

.19

<.001, 1.21 [1.15,
1.27]

82.6 (81.9, 83.5)

77.4 (76.4, 78.6)

Step 4: family history of ADHD
First degree family member with
1.24 .033
3.5 [1.5, 7.8]
85.2 (81.9, 89.3)
ADHD
Step 5: neurocognitive test cut
scores
TOVA reaction time variability
1.14 .023
3.1 [1.1, 8.9]
87.4 (86.6, 88.3)
Note. ADHD _ attention-deficit/hyperactivity disorder; BDI = Beck Depression Inventory; TOVA = Test of
Variables of Attention.

Discussion
The current study examined multiple neuropsychological test measures in conjunction with self- and informant
ratings of current and childhood ADHD symptoms in order to ascertain the extent to which inclusion of these
behavioral measures might improve the diagnostic accuracy of adult ADHD assessment. The current work sought
to extend past research in this area by examining a large battery of neuropsychological test measures as well as
several PVTs and SVTs, among a diverse sample of adults with ADHD as well as nondisordered controls and
adults with depression.
There are four sets of notable findings stemming from this work. First, our analyses found that a combined
approach that utilized self and informant ADHD symptom ratings, family history of ADHD, and
neuropsychological test measures yielded a classification accuracy of approximately 87% when distinguishing
participants with and without ADHD. Similar to past work, our findings support including retrospective ratings of
childhood symptoms, particularly inattention (Kooij et al., 2010), along with informant ratings of behavior in the
diagnostic assessment of ADHD (Sibley et al., 2017). Additionally, inclusion of ADHD family history, which is
sometimes (although not always) gathered as part of an unstructured interview, significantly increased the
classification accuracy. This suggests that it may be advantageous to gather this information in research and
clinical assessment of ADHD, even if that information is not formally part of the diagnostic criteria.
Second, our findings regarding the role of neuropsychological test measures in the diagnostic assessment of
ADHD were mixed. ROC analyses as well as linear and logistic regression analyses identified a subset of
measures that each uniquely added to the discrimination between ADHD and non-ADHD adults. These measures
included indices of working memory, inhibition, response speed and variability, and sustained attention, all
domains which largely correspond to the largest group-difference effect sizes in the ADHD neurocognitive
literature (Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). Notably, three of these six measures were from
the TOVA, suggesting that indices of response speed, response variability, and sustained attention may be
particularly important for identifying adult ADHD. However, the TOVA may have also emerged as a salient
predictor of diagnostic group due to its superior measurement precision (e.g., RTs and accuracy of performance
are measured via computer and calculated in milliseconds), which may increase the sensitivity of this test for
identifying deficits in sustained attention.
Furthermore, similar to much of the past work in this area, each single neuropsychological test measure poorly
discriminated individuals with and without ADHD, based on the ROC analyses. In fact, several measures
commonly used in clinical practice (i.e., the PASAT, NAB Numbers and Letters) were no better than chance at
distinguishing individuals with and without ADHD (i.e., controls and depressed participants) Thus, inclusion of a
long and extensive neuropsychological testing battery does not appear to yield much in terms of improving the
diagnostic accuracy of adult ADHD assessment.
Third, additional analyses of these neuropsychological test measures that aimed to maximize the sensitivity and
specificity of their prediction of ADHD diagnostic status revealed cut scores that were largely in the average
range relative to the norms developed for each measure. This may be due, in part, to the overall higher levels of
educational attainment and intellectual functioning in this sample. Some prior work has suggested that higher
intellectual functioning may potentially “mask” executive functioning deficits in particular among adults with
ADHD (Milioni et al., 2017). Further, these findings are in line with past work, which has suggested that adults
with ADHD may exhibit less severe neuropsychological impairment (Salomone, Fleming, Bramham, O’Connell, &
Robertson, 2016), but may instead show more heterogeneity in terms of degree and types of cognitive deficits
(Mostert et al., 2018). Regardless, this set of findings may be particularly relevant in the assessment of ADHD
among college students. That is, adults with above average global cognitive abilities may underperform on some
of these tasks relative to their IQ, even though their performance may be within an average range when
compared with a broader population of adults. (Weyandt et al., 2013).

Further, our findings of average-range cut scores that discriminated ADHD and non-ADHD participants within
our sample may also explain findings from prior work regarding the lack of utility of neuropsychological tests in
diagnosing adult ADHD. That is, neuropsychological tests may not have appeared to be useful for diagnosis in
some prior work if an individual had to score substantially below the included norms (rather than low relative to
a comparison or peer group) to be deemed impaired on a particular measure. While this may not account for all
of the mixed findings in past research regarding the utility of neuropsychological tests in diagnosing adult ADHD,
our findings strongly suggest that the criteria used to identify impairment on any neuropsychological tests be
considered carefully and in relation to the individual’s appropriate reference group (e.g., college-educated
adults, high-average intellectual functioning). Future work may benefit by developing college-level norms for
some measures commonly used in neuropsychological research and in evaluations of young adults with ADHD
(Weyandt et al., 2013).
Fourth, our findings did not reveal many problems with invalid symptom presentation based on the results of
PVTs and a symptom validity measure. Only 2% of the participants in this study were identified as making an
invalid symptom presentation (i.e., below thresholds on 2 or more PVTs/SVTs). This is a substantially lower
percentage than those found in studies of young adult patients presenting for ADHD assessment in clinical
settings. Based on the conservative Slick, Sherman, and Iverson (1999) malingering criteria, prior work has
estimated that 27% (Marshall et al., 2016), 22% (Marshall, et al., 2010), and 10% (Pella, Hill, Shelton, Elliott, &
Gouvier, 2012) of college students made a suspect effort in their cognitive assessments. However, the
participants in the current study had already been diagnosed with ADHD and their retaining this diagnosis was
not in question. Therefore, it is highly likely that the participants in our study did not have the same set of
incentives or motivations for making an invalid symptom presentation. Unfortunately, this unusually small
percentage of individuals making an invalid symptom presentation prevented this study from producing
meaningful data concerning the incremental predictive validity of including validity measures in an ADHD
assessment battery. Nevertheless, prior work and clinical practice guidelines have strongly supported the need
for such PVTs in order to identify invalid symptom presentation in this group, which may obscure clinical
assessment and diagnosis of adults with ADHD (Bush et al., 2005; Heilbronner et al., 2009; Marshall et al., 2016;
Tucha, Fuermaier, Koerts, Groen, & Thome, 2015).
Overall, our findings supported including the following measures in a diagnostic assessment of ADHD (in
addition to the clinical interview): (a) self-reports of ADHD, functional impairment, and potential comorbid
problems, including depression; (b) retrospective reports of childhood ADHD symptoms; (c) informant reports of
symptoms; (d) any positive family history of ADHD diagnoses; (e) performance and symptom validity measures;
and (f) the TOVA or similar computerized continuous performance task. While our findings only offer some
support for inclusion of neuropsychological tests in the diagnostic assessment of adult ADHD, more work is
needed to determine if such tests significantly benefit diagnostic decision making in situations in which the
results of other means of assessment (i.e., rating scales, clinical interview) are equivocal. Additionally, while
these neuropsychological measures may slightly increase diagnostic accuracy, assessments of neurocognitive
functioning, via testing or behavior ratings (e.g., the BDEFS), may be beneficial for understanding impairment
and treatment targets in studies of intervention (Kooij et al., 2010; Solanto et al., 2010). Further, recent work
focusing on neuropsychological test performance among adults with ADHD has demonstrated significant
heterogeneity in performance across individuals (van Lieshout et al., 2013), some of which does not appear to
be connected to the persistence or remittance of ADHD symptoms. Indeed, recent controversial work has even
suggested that adult-onset ADHD may be a separate syndrome and associated with disparate risk factors and
outcomes (Moffitt et al., 2015), although this possibility has also been questioned (Agnew-Blais et al., 2016).
There are several limitations to the current work. First, while our battery was comprehensive, some potentially
ADHD-related behavioral problem domains may not have been properly covered in our measures. Measures of
reward responsivity (von Rhein et al., 2015; Wetterling et al., 2015), emotional dysregulation (Barkley, 2015),
and temporal discounting (Jackson & MacKillop, 2016), in particular, may provide additional utility in

distinguishing adults with and without ADHD. Second, the limited precision of cognitive processing speed
measurement on some tasks may have limited their utility. Future work may benefit by incorporating
computerized measures of several of these tasks to determine if improvement in cognitive processing speed
measurement precision may enhance their usefulness in clinical assessment. For example, computerized
working memory tests that include speed and accuracy measures might significantly increase the sensitivity of
these tests to ADHD-related deficits (Alderson et al., 2013).
This work was also limited by considering only one clinical comparison group (e.g., depression). Examination of
the degree to which these measures may distinguish among those with ADHD and other common comorbidities
in adulthood, particularly anxiety disorders, as well as the impact of comorbid ADHD and internalizing symptoms
on multiple domains of cognitive functioning, will be essential to future research in this area. We also excluded
many individuals with comorbid neurodevelopmental problems (e.g., learning disorders). While there is
evidence of shared deficits among individuals with ADHD and learning disorders, and enhanced deficits among
those with comorbid profiles, we elected to exclude individuals with learning disorders in the current study. This
decision may have then actually contributed to an underestimation of group differences observed, given that
these excluded individuals with comorbid profiles may have performed equally poor or worse on our test
battery relative to those with ADHD alone. Additionally, the relative smaller size of the depressed group may
limit the generalizability of our findings regarding distinctions (or lack thereof) in cognitive performance among
adults with ADHD and those with depressive disorders.
Future work would also benefit by examining neuropsychological tests and symptom validity measures as
predictors of ADHD diagnosis in particular cases in which traditional clinical interviews and rating scales have
produced equivocal findings. That is, some of these measures may not have considerable utility in distinguishing
those individuals at the extreme end of the symptomatology distributions (i.e., those with severe ADHD
symptoms, those with no ADHD symptoms). However, they may be more useful in distinguishing among those in
the middle portion of the symptom severity distribution, particularly given the arbitrary nature of diagnostic cut
points. That is, the utility of neuropsychological tests in identifying ADHD may indeed vary as a function of
symptom severity.
Lastly, our sample was limited to volunteer research participants who were predominately Caucasian and who
had completed a college degree. These three factors (self-selection, ethnic homogeneity, higher education level)
may limit the generalizability of our findings. It is also important to note that we implemented multiple
measures of symptom and performance validity into our battery, in line with current concerns regarding adults
feigning ADHD (see the December 2017 issue of Psychological Assessment including Fuermaier et al., 2017;
Walls, Wallace, Brothers, & Berry, 2017). However, our ADHD participants had already been diagnosed
previously, which may be one reason that our validity measures revealed few participants with questionable
performance. Even so, examination of symptom and performance validity remains of paramount concern in
assessment of adult ADHD.
Overall, findings from the current study indicated that neuropsychological testing added incrementally in
predicting ADHD diagnoses among young adults. However, effects were small and the utility of individual tests
was modest in the absence of other assessment information. A diagnostic protocol that included self- and
informant ratings of current and childhood symptoms, family history of ADHD, and performance on a continuous
performance test had high classification accuracy and appeared to be the most efficient in diagnosing ADHD
among adults. Future work should incorporate performance and validity assessments as well as determine the
utility of this battery in predicting ADHD diagnosis and related impairments across the spectrum of ADHD
symptom severity.
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